Anthropic's proposed IPO: understanding a base offer of up to $64bn
Anthropic's proposed base offer could reach $64.35bn. Rapid revenue growth and a narrowing operating loss strengthen the case, but the price and funding commitments still matter.
5 min read
Anthropic's proposed IPO has two numbers worth putting next to each other. Its base share sale could reach $64.35 billion. Its revenue for the first nine months of 2026 was $33.24 billion, more than 13 times the comparable period a year earlier.
The first tells us about the fundraising. The second helps explain why investors might want to fund it. Neither tells us whether the shares offer a good return at the price a buyer will actually pay.
My view is that the interesting argument has moved beyond whether people will pay for Claude. The filing shows a substantial business. The harder questions are how much of that growth can become lasting profit, how much capital it requires and how much success the share price already assumes.
What the $64bn figure measures
The 17 November prospectus proposes selling 825 million shares at an indicative $70 to $78 each. That puts the base offer between $57.75 billion and $64.35 billion, before fees and expenses.
The shares on offer are only part of the company. The sale's size is therefore different from its valuation, which depends on the wider share count and the rights attached to those shares. A quoted price per share is not a useful measure of cheapness on its own either: a company can change that number through a share split without changing the business's value.
For an investor, the relevant comparison is between the price of an ownership stake and the cash that stake might eventually earn. The fundraising headline leaves most of that work undone.
Most of the money would go into the business
Anthropic would issue about 801.4 million new shares, while existing holders would sell about 23.6 million. At the $74 midpoint, roughly $59.30 billion would go to Anthropic and $1.75 billion to selling shareholders, before costs.
Around 97% of the base offer would therefore be new funding for the company. I would focus on the use of that capital. A large injection of money can give a growing business valuable room to expand; it also gives investors a much larger investment programme to judge.
Who would receive the base IPO proceeds?
Gross proceeds at the low end, midpoint and high end of the indicative range ($bn)
Stacked bar chart of gross base IPO proceeds at $70, $74 and $78 per share. New shares sold by Anthropic account for $56.09bn, $59.30bn and $62.51bn respectively; shares sold by existing holders account for $1.66bn, $1.75bn and $1.84bn. Total base offer sizes are $57.75bn, $61.05bn and $64.35bn. All values are before costs, exclude the underwriters’ option and the separate private placement, and the terms are preliminary.
Gross base offer proceeds
US dollars, billions
- Anthropic: new shares
- Selling shareholders: existing shares
Indicative range; gross proceeds before costs. Excludes the underwriters’ option and the separate private placement.
Source: Anthropic amended S-1, 17 November 2026; author’s calculations
View data
| Category | Anthropic: new shares | Selling shareholders: existing shares | Total |
|---|---|---|---|
| $70 per share | $56,094,594,780 | $1,655,405,220 | $57,750,000,000 |
| $74 per share | $59,300,000,196 | $1,749,999,804 | $61,050,000,000 |
| $78 per share | $62,505,405,612 | $1,844,594,388 | $64,350,000,000 |
The base offer excludes an option for the underwriters to buy another 123.75 million new shares. A separate $26 billion private placement is conditional on the IPO closing and other requirements being met. Neither belongs inside the $64.35 billion base-offer figure.
The growth deserves to be taken seriously
The unaudited nine-month accounts give the optimistic case some substance. Revenue rose from $2.55 billion to $33.24 billion between the first nine months of 2025 and the same period in 2026. Operating expenses rose too, but the operating loss narrowed from $5.22 billion to $1.26 billion.
Revenue has almost caught up with operating expenses
Nine months ended 30 September, 2025 and 2026 ($bn)
Paired-dot chart compares revenue and total operating expenses for the first nine months of 2025 and 2026. Revenue rose from $2.545bn to $33.242bn. Operating expenses rose from $7.769bn to $34.502bn. The operating loss narrowed from $5.224bn to $1.260bn.
Revenue and operating expenses
US dollars, billions
- Jan-Sep 2025
- Jan-Sep 2026
Unaudited nine-month results. Operating expenses include compute, staff and other operating costs; the operating result excludes financing-related fair-value changes.
Source: Anthropic amended S-1, 17 November 2026, consolidated statements of operations (F-7)
View data
| Category | Jan-Sep 2025 | Jan-Sep 2026 |
|---|---|---|
| Revenue | $2,545,000,000 | $33,242,000,000 |
| Operating expenses | $7,769,000,000 | $34,502,000,000 |
That is a stronger picture than a story in which sales and losses simply grow together. Over this period, revenue caught up with a large part of the operating cost base. I would not dismiss that improvement just because the scale of the financing is uncomfortable.
There is a reasonable case for raising money while demand is growing quickly: capacity that arrives late cannot serve a customer today. If additional spending supports profitable future sales, issuing shares can make existing and new investors better off despite the larger share count.
But the word "if" does real work. Investors need the demand to last long enough, and the returns to be attractive enough, to justify the capital committed ahead of it.
The $104bn loss needs a closer look
The same accounts report a net loss of about $104.04 billion for those nine months. That sounds incompatible with an improving business until the components are separated.
About $94.32 billion came from a change in the fair value of convertible notes, derivative liabilities and related financing instruments. This was a non-cash accounting charge. It should not be read as $94 billion spent operating Claude.
The cash-flow statement records $6.57 billion generated by operating activities over the period. The cash-flow statement starts from the accounting loss, adjusts for non-cash charges and then reflects when customers and the business pay their bills. Investment spending sits elsewhere, so this inflow is not a measure of cash left after funding expansion.
I would use the operating result to understand progress in the business, the cash-flow statement to understand funding, and the financing notes to understand the unusually large net loss. Choosing only the most flattering or alarming number would obscure more than it reveals.
More demand means more capacity to finance
Anthropic says it expects a growing share of its infrastructure investment to require upfront payments, including capital spending and leases, before the computing capacity is available. It expects net cash use across operating and investing activities as it builds out, and says that use could increase even if financial performance improves. The positive operating cash flow so far this year should be read against that warning.
That makes the timing of growth important. A contract for capacity creates an obligation; future customer demand still has to arrive. If demand disappoints, a business may have committed to costs it cannot quickly remove. If demand exceeds expectations, it may need still more capital to serve it.
The filing itself flags a further potential conflict: some infrastructure and chip partners provide capital or credit support while also offering competing AI services. That does not make the arrangements inherently bad. It does make access, pricing and bargaining power part of the investment case.
The optimistic interpretation is that scale and funding help Anthropic meet demand and improve its economics. What remains open is how much of the resulting value stays with its shareholders after paying for the infrastructure, people and distribution needed to deliver it.
The price can undo a good investment story
Even a business that fulfils a promising forecast can disappoint an investor who pays too much for it. The purchase price determines how much improvement is already required before the buyer earns an attractive return.
That is why I would be cautious about using a possible first-day jump as evidence of value. The offer price and the price available once trading begins can differ substantially. Someone who buys after a rise has paid more for the same ownership stake.
Consider a simple illustration: a share bought for £100 and later worth £150 has gained 50%. Someone who paid £125 for that same share has gained 20%. The business arrived at the same outcome; the entry price changed the investment result.
Bond yields also affect the appeal of expensive growth shares, because investors can compare uncertain future profits with other available returns. Strong sales growth does not remove that comparison.
For me, Anthropic's filing makes a credible case that a very large business is being built. The narrowing operating loss gives that case more weight. The proposed IPO still asks buyers to judge the price, the funding commitments and the durability of the economics together. Admiring the product is the easy part of that decision.
Comments
No comments yet - start the conversation.